Overview
Watchlist
Equities
Crypto
Soon
Popular
Cookies
Terms of Service
Privacy Policy
Home
© 2026 FYStats. 
Home
Equities
RGNT
Fundamentals

Regentis Biomaterials Ltd.

RGNT

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

0.00
0.000.00%
-

Assets

7.62M
▲7.14M▲1480.50%
12 Months Change

Liabilities

2.87M
▼-3.61M▼-55.70%
12 Months Change

Free Cash Flow

0.00
0.000.00%
-

Revenue/Cost Of Revenue

Loading...

Net Profit/Loss

Loading...

Assets/Liabilities

Loading...

Cash Flows

Loading...

Earnings Per Share

Loading...

Outstanding Shares

Loading...

Recent Quarterly and Annual Filings

2026-02-24
Form 20-F
ID: 0001213900-26-019917